NCT03735173

Brief Summary

Participants who choose to participate in this study, will either have their tendon repaired to tendon, so-called tenotomy repair, or tendon repaired to bone, so-called peel repair.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 8, 2018

Completed
23 days until next milestone

Study Start

First participant enrolled

December 1, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 7, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 7, 2021

Completed
Last Updated

August 12, 2021

Status Verified

August 1, 2021

Enrollment Period

2.4 years

First QC Date

October 4, 2018

Last Update Submit

August 5, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Function of Subscapularis muscle as measured by belly-press test

    5 years

  • Radiographic loosening

    "glenoid at risk" proportion

    5 years

Study Arms (4)

Pegged through SP

ACTIVE COMPARATOR

Primary anatomic shoulder arthroplasty with implantation of a cemented all-polyethylene pegged glenoid component through a Subscapularis Peel (SP) manipulation.

Procedure: ReUnion TSA, pegged design

Pegged through ST

ACTIVE COMPARATOR

Primary anatomic shoulder arthroplasty with implantation of a cemented all-polyethylene pegged glenoid component through subscapularis tenotomy (ST) manipulation.

Procedure: ReUnion TSA, pegged design

Keeled through SP

ACTIVE COMPARATOR

Primary anatomic shoulder arthroplasty with implantation of a cemented all-polyethylene keeled glenoid component through a Subscapularis Peel (SP) manipulation.

Procedure: ReUnion TSA, keeled design

Keeled through ST

ACTIVE COMPARATOR

Primary anatomic shoulder arthroplasty with implantation of a cemented all-polyethylene keeled glenoid component through subscapularis tenotomy (ST) manipulation.

Procedure: ReUnion TSA, keeled design

Interventions

ReUnion total shoulder arthroplasty system, pegged design

Pegged through SPPegged through ST

ReUnion total shoulder arthroplasty system, keeled design

Keeled through SPKeeled through ST

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects willing to sign the informed consent
  • Male and female subjects ages 18 - 90 at the time of surgery
  • Subjects indicated for an anatomic total shoulder arthroplasty (including primary glenohumeral osteoarthritis, avascular necrosis, and inflammatory arthritis)

You may not qualify if:

  • Inability to comply with follow-up requirements
  • Known or presumed substantial rotator cuff disorders
  • Subjects with an active or suspected latent infection in or about the shoulder
  • Subjects with instability (surgically or non-surgically addressed)
  • Subjects presenting with posttraumatic avascular necrosis
  • Need for glenoid bone grafting
  • Pregnant subjects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Shoulder PainOsteonecrosisArthritis

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBone DiseasesNecrosisPathologic Processes

Study Officials

  • Mark Morrey, M.D.

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 4, 2018

First Posted

November 8, 2018

Study Start

December 1, 2018

Primary Completion

May 7, 2021

Study Completion

May 7, 2021

Last Updated

August 12, 2021

Record last verified: 2021-08

Locations